New Zealand - English - Medsafe (Medicines Safety Authority)

fresenius kabi new zealand limited - glucose monohydrate 20.9% equivalent to 19% glucose anhydrous;  ;  ;  ; alanine 1.6%;  ;  ;  ; arginine 1.13%;  ;  ;  ;  ; aspartic acid 0.34%;  ;  ;  ;  ;  ; calcium chloride dihydrate 0.074%;  ; glutamic acid 0.56%;  ;  ;  ;  ;  ; glycine 0.79%;  ;  ;  ;  ;  ; histidine 0.68%;  ;  ;  ;  ; isoleucine 0.56%;  ;  ;  ;  ;  ; leucine 0.79%;  ;  ;  ;  ;  ; lysine hydrochloride 0.9%;  ;  ;  ;  ;  ;  ; magnesium sulfate heptahydrate 0.16%;  ;  ; methionine 0.56%;  ;  ;  ;  ;  ; phenylalanine 0.79%;  ;  ;  ;  ;  ; potassium chloride 0.597%;  ; proline 0.68%;  ; serine 0.45%;  ;  ;  ;  ; sodium acetate trihydrate 0.49%;  ;  ; sodium glycerophosphate 0.54%;  ;  ;  ; threonine 0.56%;  ;  ;  ; tryptophan 0.19%;  ;  ;  ; tyrosine 0.023%;  ;  ;  ; valine 0.73%;  ;  ;  ;  ; soya oil 20% - emulsion for injection - active: glucose monohydrate 20.9% equivalent to 19% glucose anhydrous       excipient: water for injection active: alanine 1.6%       arginine 1.13%         aspartic acid 0.34%           calcium chloride dihydrate 0.074%   glutamic acid 0.56%           glycine 0.79%           histidine 0.68%         isoleucine 0.56%           leucine 0.79%           lysine hydrochloride 0.9%             magnesium sulfate heptahydrate 0.16%     methionine 0.56%           phenylalanine 0.79%           potassium chloride 0.597%   proline 0.68%   serine 0.45%         sodium acetate trihydrate 0.49%     sodium glycerophosphate 0.54%       threonine 0.56%       tryptophan 0.19%       tyrosine 0.023%       valine 0.73%         excipient: glacial acetic acid water for injection active: soya oil 20% excipient: egg lecithin glycerol sodium hydroxide water for injection - parenteral nutrition for adult patients and children above 2 years of age when oral or enteral nutrition is impossible or insufficient or contraindicated.

New Zealand - English - Medsafe (Medicines Safety Authority)

fresenius kabi new zealand limited - glucose monohydrate 12.1% equivalent to 11% glucose anhydrous;  ;  ;  ; alanine 1.6%;  ;  ;  ; arginine 1.13%;  ;  ;  ;  ; aspartic acid 0.34%;  ;  ;  ;  ;  ; calcium chloride dihydrate 0.074%;  ; glutamic acid 0.56%;  ;  ;  ;  ;  ; glycine 0.79%;  ;  ;  ;  ;  ; histidine 0.68%;  ;  ;  ;  ; isoleucine 0.56%;  ;  ;  ;  ;  ; leucine 0.79%;  ;  ;  ;  ;  ; lysine hydrochloride 0.9%;  ;  ;  ;  ;  ;  ; magnesium sulfate heptahydrate 0.16%;  ;  ; methionine 0.56%;  ;  ;  ;  ;  ; phenylalanine 0.79%;  ;  ;  ;  ;  ;  ; potassium chloride 0.597%;  ; proline 0.68%;  ; serine 0.45%;  ;  ;  ;  ;  ; sodium acetate trihydrate 0.49%;  ;  ; sodium glycerophosphate 0.54%;  ;  ; threonine 0.56%;  ;  ;  ; tryptophan 0.19%;  ;  ;  ; tyrosine 0.023%;  ;  ;  ; valine 0.73%;  ;  ;  ;  ; soya oil 20% - emulsion for injection - active: glucose monohydrate 12.1% equivalent to 11% glucose anhydrous       excipient: water for injection active: alanine 1.6%       arginine 1.13%         aspartic acid 0.34%           calcium chloride dihydrate 0.074%   glutamic acid 0.56%           glycine 0.79%           histidine 0.68%         isoleucine 0.56%           leucine 0.79%           lysine hydrochloride 0.9%             magnesium sulfate heptahydrate 0.16%     methionine 0.56%           phenylalanine 0.79%             potassium chloride 0.597%   proline 0.68%   serine 0.45%           sodium acetate trihydrate 0.49%     sodium glycerophosphate 0.54%     threonine 0.56%       tryptophan 0.19%       tyrosine 0.023%       valine 0.73%         excipient: glacial acetic acid water for injection active: soya oil 20% excipient: egg lecithin glycerol sodium hydroxide water for injection - parenteral nutrition for adult patients and children above 2 years of age when oral or enteral nutrition is impossible or insufficient or contraindicated.

Australia - English - Department of Health (Therapeutic Goods Administration)

bppr consulting - glucose monohydrate -

Australia - English - Department of Health (Therapeutic Goods Administration)

fresenius kabi australia pty ltd - glucose, quantity: 12.5 g - injection, solution - excipient ingredients: water for injections; hydrochloric acid; sodium hydroxide - the solutions are indicated for intravenous fluid therapy designed to correct deficiencies in energy levels. glucose 5% is also used to correct hydration levels. the solutions may also be used as solvents for intravenously administered drugs where compatibility has been established.

Australia - English - Department of Health (Therapeutic Goods Administration)

fresenius kabi australia pty ltd - glucose, quantity: 5 g - injection, solution - excipient ingredients: water for injections; sodium hydroxide; hydrochloric acid - the solutions are indicated for intravenous fluid therapy designed to correct deficiencies in energy levels. glucose 5% is also used to correct hydration levels. the solutions may also be used as solvents for intravenously administered drugs where compatibility has been established.

Australia - English - Department of Health (Therapeutic Goods Administration)

fresenius kabi australia pty ltd - glucose, quantity: 2.5 g - injection, solution - excipient ingredients: water for injections; sodium hydroxide; hydrochloric acid - the solutions are indicated for intravenous fluid therapy designed to correct deficiencies in energy levels. glucose 5% is also used to correct hydration levels. the solutions may also be used as solvents for intravenously administered drugs where compatibility has been established.

Australia - English - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - soya oil, quantity: 16.38 g; olive oil, quantity: 13.65 g; medium chain triglycerides, quantity: 13.65 g; fish oil - rich in omega-3 acids, quantity: 10.92 g - injection, emulsion - excipient ingredients: egg lecithin; glycerol; sodium oleate; dl-alpha-tocopherol; sodium hydroxide; water for injections - finomel is indicated for parenteral nutrition in adult patients when oral or enteral nutrition is impossible, insufficient or contraindicated.

Australia - English - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - soya oil, quantity: 12.36 g; olive oil, quantity: 10.3 g; medium chain triglycerides, quantity: 10.3 g; fish oil - rich in omega-3 acids, quantity: 8.24 g - injection, emulsion - excipient ingredients: egg lecithin; glycerol; sodium oleate; dl-alpha-tocopherol; sodium hydroxide; water for injections - finomel is indicated for parenteral nutrition in adult patients when oral or enteral nutrition is impossible, insufficient or contraindicated.

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

nutrien ag solutions limited - glucose - parenteral liquid/solution/suspension - glucose carbohydrate active 400.0 g/l - nutrition & metabolism - cattle | sheep pregnant | beef | bos indicus | bos taurus | bovine | buffalo | bull | bullock | calf | cow | dairy cow | heifer - ketosis | mineral and nutritional additive | acetonaemia | actinobacillosis | amino acid supplement | amino acids | bone fragility | bone growth | calcium supplement | cartilage strength | copper deficiency | egg shell | elevated ketones | fatty acid deficiency | fatty liver | glucose | grass tetany | hepatotoxic drugs | hypocalcaemia | hypomagnesaemia | ileitis | iodine deficiencies | lactating | laxative | l-carnitine supplement | liver abscess | liver damage | lysine deficiencies | milk fever | mineral additive | myopathies | myositis syndrome | non-clinical ketosis | pangamic acid | phosphorous supplement | rickets | selenium deficiency | shell strength | soft bone disease | vitamin b12 | vitamin d supplement | vitamin e deficiencies | zinc deficiencies

Israel - English - Ministry of Health

baxter healthcare distribution ltd., israel - calcium chloride dihydrate; glucose monohydrate (as anhydrous); lactic acid as sodium; magnesium chloride hexahydrate; sodium bicarbonate; sodium chloride - solution for peritoneal dialysis - sodium chloride 5.38 g/l; magnesium chloride hexahydrate 0.051 g/l; lactic acid as sodium 1.68 g/l; sodium bicarbonate 2.10 g/l; glucose monohydrate (as anhydrous) 13.6 g/l; calcium chloride dihydrate 0.184 g/l - sodium chloride - sodium chloride - physioneal is indicated whenever peritoneal dialysis is employed including:acute and chronic renal failure severe water retention severe electrolyte imbalance drug intoxication with dialysable substances when a more adequate therapeutic alternative is not available. bicarbonate/lactate based physioneal peritoneal dialysis solutions with a physiological ph are particularly indicated in patients in whom solutions based on lactate buffer only with a low ph cause abdominal inflow pain or discomfort.